REVANCE THERAPEUTICS

Revance Therapeutics is a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems, Inc. Revance Therapeutics, Inc. was founded in 2002 and is based in Mountain View, California.

#SimilarOrganizations #People #Financial #Website #More

REVANCE THERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Pharmaceutical Therapeutics

Founded:

2002-01-01

Address:

Newark, California, United States

Country:

United States

Website Url:

http://www.revance.com

Total Employee:

101+

Status:

Active

Contact:

+1 510 742 3400

Email Addresses:

[email protected]

Total Funding:

1.49 B USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins

Similar Organizations

1717-life-science-ventures-logo

1717 Life Science Ventures

1717 Life Science Ventures develops precision radiopharmaceuticals for the diagnosis and treatment of malignant oncological diseases.

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

lucy-therapeutics-logo

Lucy Therapeutics

Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.

pliant-therapeutics-logo

Pliant Therapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

proventiv-therapeutics-logo

Proventiv Therapeutics

Proventiv Therapeutics develops and commercializes pharmaceutical products to treat and prevent the clinical consequences of diseases.

not_available_image

Secant Therapeutics

Secant Therapeutics develops a percutaneous transcatheter direct plication annuloplasty (DPA) device.

Current Advisors List

mark-foley_image

Mark Foley Board Member @ Revance Therapeutics
Board_member
2017-09-01

phyllis-gardner_image

Phyllis Gardner Director @ Revance Therapeutics
Board_member

bob-byrnes_image

Bob Byrnes Independent Director @ Revance Therapeutics
Board_member

david-l-douglass_image

David L. Douglass Board Observer @ Revance Therapeutics
Board_observer

jim-glasheen_image

Jim Glasheen Board Director @ Revance Therapeutics
Board_member

Current Employees Featured

todd-gross_image

Todd Gross
Todd Gross Vice President, Biostatistics & Data Management @ Revance Therapeutics
Vice President, Biostatistics & Data Management
2018-08-01

abhay-joshi_image

Abhay Joshi
Abhay Joshi COO, President of R&D and Product Operations @ Revance Therapeutics
COO, President of R&D and Product Operations
2015-12-01

ben-de-waal_image

Ben de Waal
Ben de Waal Vice President, Platform Research and Development @ Revance Therapeutics
Vice President, Platform Research and Development
2020-07-01

mark-foley_image

Mark Foley
Mark Foley President & CEO @ Revance Therapeutics
President & CEO
2019-10-01

not_available_image

Sharon Hall
Sharon Hall Vice President, Regulatory Affairs @ Revance Therapeutics
Vice President, Regulatory Affairs

tobin-schilke_image